Ramsay is proud to play a leading role in Australia’s health and medical research sector by driving research through the Ramsay Research & Development Network, the Ramsay Hospital Research Foundation, and our Research Ethics, and Governance Unit.
The Clinical Trials and Research Unit at Ramsay Clinic Albert Road is part of the Ramsay Research & Development Network that operates across 20+ Ramsay Health Care facilities throughout Australia. Our hospital actively encourages and supports clinical research as a key contributor to improved patient outcomes. We believe that providing early access to promising clinical trials is essential to delivering high-quality, leading-edge care, consistent with the standard of care at our hospital.
Our hospital has a dedicated clinical trials & research unit that supports the conduct of research across all aspects of the hospital. Our site manager and the broader research team can provide advice on how to get involved.
Contact the Clinical Trials and Research Manager via email at research.arc@ramsayhealth.com.au
All research conducted at Ramsay Clinic Albert Road requires local endorsement, as well as Ethics & Research Governance Approval. If you are interested in conducting research the following steps will need to be taken:

This first step allows the hospital to review the proposed research and ensure that it is appropriate to be conducted at the hospital. This guarantees the researcher has confirmation early that the hospital is able to provide the necessary infrastructure, people or access that will be required and once approved, the research will be established seamlessly.
To apply for Research Endorsement, please use this form.
Once completed, applicants should email this form to research.arc@ramsayhealth.com.au
This form should be completed by Principal Investigators, students, or nursing and allied health professionals and our internal research teams. Direct submission of this form from CROs or Industry Sponsors will not be accepted.
Ramsay will accept research ethics approvals from any NHMRC endorsed Human Research Ethics Committee, provided that committee is willing to oversee the research in Ramsay.
Ramsay also maintains a Human Research Ethics Committee who can assist where an applicant has not previously sought ethics approval. Further information about Ramsay’s processes can be found here.
It is a requirement of Ramsay Health Care that all research applications receive research governance approval prior to any research commencing at the hospital.
Applications for Research Governance can be submitted through the REGGS platform.
All questions relating to Research Governance can be directed to the following email address: ResearchGovernance@ramsayhealth.com.au or call the Ramsay National Research Unit on (02) 9433 3854.
If you’re interested in participating in a clinical trial, you may be eligible for one currently being conducted at Ramsay Clinic Albert Road as listed below. Please speak with your doctor to explore your options. If you’re interested in participating in a clinical trial, not offered at Ramsay Clinic Albert Road, your doctor may be able to help you find another trial appropriate for you. Alternatively, you can search for suitable clinical trials through the Australian Clinical Trials website or ClinTrial Refer.
For any inquiries, please contact Clinical Trials and Research Manager via email at research.arc@ramsayhealth.com.au
Please browse below our current research trials. Should you wish to enquire about a specific trial, take note of the trial's unique protocol number and contact us using the contact form under the list of trials. To explore Ramsay Health Care's broader research opportunities please visit Ramsay Research.
| An Efficacy and Safety, Phase III, Multi-center, Double-Blind, Randomized Controlled Study Comparing 2 Active Doses of CYB003 and Placebo in Eligible Participants with Major Depressive Disorder (EMBRACE) | |
|---|---|
| Protocol No | CYB003-003 |
| Description | Efficacy and Safety of CYB003 for Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial |
| Sponsor/Funding | Worldwide Clinical Trial Pty Ltd |
| Click here for more information | |
| The Candesartan Adjunctive Bipolar Depression Trial - CADET: A double-blind, randomised, placebo-controlled trial | |
|---|---|
| Protocol No | CADET BD |
| Description | This study will test if a well-known blood pressure medication Candesartan may help recovery for people with Bipolar Depression. |
| Sponsor/Funding | Deakin University / Medical Research Future Fund |
| Click here for more information | |
| Efficacy and Safety of HB-1 for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial | |
|---|---|
| Protocol No | HB-PD-002 |
| Description | Efficacy and Safety of HB-1 for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial |
| Sponsor/Funding | Accelagen Pty Ltd |
| Click here for more information | |
Would you like to be a part of ground breaking medical research? Some of the Research conducted at the Ramsay Clinic Albert Road involves Healthy Volunteers as part of the control group or placebo group. This may involve participation in questionnaires, medical assessments or using diagnostic equipment. Travel costs, meals or time may be reimbursed depending on the Research, the participation required and time involved.
Health Volunteers play a very important role in improving healthcare options for the community, please consider volunteering today via the Contact Us form below.
Ramsay Health Care has partnered with the charity Someone Who Cares to establish an efficient and effective program of distributing medical equipment and goods to disadvantaged communities in Australia and overseas.
RCARRU proudly donates unused research laboratory supplies to communities in need while also reducing unnecessary landfill.
Ramsay Health Care has partnered with Clin Trial Refer, a mobile app and website platform which allows doctors and patients to independently search for actively recruiting clinical trials and to access trial site locations and contact details in real time.
To stay informed about future research opportunities please reach out to us via, email, phone or the contact us form below.
Email: researchrecruitment.arc@ramsayhealth.com.au
Phone: 03 9279 3569
For more information about Research throughout the Ramsay network, please visit Ramsay Research.
|
Sjacko Sobczak, Vasiliki Orgeta, Margreet Beenakker, Marco Boks, Margherita Boltri, Monica Cations, Estelle Coeur, Joan M Cook, Xavier Corveleyn, Ashley-Nicole Dorame, Gea C van Dijk, Barbara Forresi, Stéfanie Fréel, Denise Gómez-Bautista, Mia Maria Günak, Demi CD Havermans, Malcolm Hopwood et al The Lancet Healthy Longevity |
2025 |
|
Matthew JY Kang, Dhamidhu Eratne, Olivia Dean, Michael Berk, Adam J Walker, Cassandra Wannan, Charles B Malpas, Claudia Cicognola, Shorena Janelidze, Oskar Hansson, Jasleen Grewal, Philip B Mitchell, Malcolm Hopwood, Christos Pantelis, Alexander F Santillo, Dennis Velakoulis Bipolar Disorder |
2025 |
|
REPURPOSING CANDESARTAN, THE ANTIHYPERTENSIVE DRUG, FOR TREATMENT OF BIPOLAR DISORDER Johnny Park, Melanie Ashton, Judy Hope, Chee Ng, Malcolm Hopwood, Jon-Paul Khoo, Gin Malhi, Brisa Fernandes, Stella May Gwini, John Amerena, Trisha Suppes, Mary Lou Chatterton, Lana Williams, Adam Walker, Alyna Turner, Andre Carvalho, Andrew Nierenberg, Emily Moriaty, Lars Kessing, Mohammedreza Mohebbi, Seetal Dodd, Steven Moylan, Jose Segal, John Tiller, Joel King, Jeremy Couper, Jee Hyun Kim, Olivia Dean, Michael Berk International Journal of Peuopsychopharmacology |
2025 |
|
Melanie Hurley, Angela Komiti, Malcolm Hopwood Australasian Psychiatry |
2025 |
|
Colleen Loo, Ana Rita Barreiros, Donel Martin, Vanessa Dong, Mark S George, William V McCall, Shanthi Sarma, Malcolm Hopwood, Alan Weiss, Michael Bull, Clara M Tuneu, Angelo Alonzo, Dusan Hadzi-Pavlovic, Anthony Rodgers, Gregory L Sahlem, Anna J Harvey, Kate Haldane, Louise Brettell, Paul B Fitzgerald, Socrates Dokos, Harold Sackeim The Journal of ECT |
2024 |
|
Apathy and Affective Symptoms Associated with Elevated Alzheimer’s Disease Biomarkers Matthew JY Kang, Dhamidhu Eratne, Samantha M Loi, Christa Dang, Alexander F Santillo, Henrik Zetterberg, Kaj Blennow, Philip B Mitchell, Malcolm Hopwood, Charles B Malpas, Dennis Velakoulis, Alzheimer’s Disease Neuroimaging Initiative medRxiv |
2024 |
|
Matthew JY Kang, Jasleen Grewal, Dhamidhu Eratne, Charles Malpas, Wei-Hsuan Chiu, Kasper Katisko, Eino Solje, Alexander F Santillo, Philip B Mitchell, Malcolm Hopwood, Dennis Velakoulis Brain, Behaviour and Immunity |
2024 |
|
Vanessa Dong, Louise Brettell, Clara Massaneda-Tuneu, Ana Rita Barreiros, Thanh Vinh Cao, Catherine Kelly, Yucheng Zeng, Nobuatsu Aoki, Phern-Chern Tor, Adam Bayes, Grace Branjerdporn, Shanthi Sarma, Elaine Kwan, Sue Waite, Titus Mohan, Salam Hussain, Verónica Gálvez, Alan Weiss, Michael Bull, Mary Lou Chatterton, Cathrine Mihalopoulos, Nick Glozier, Dusan Hadzi-Pavlovic, Malcolm Hopwood, Philip Mitchell, Brian Power, Grant Sara, Karen Wells, Colleen Loo, Donel Martin Australia & New Zealand Journal of Psychiatry |
2024 |
|
Malcolm Hopwood, Elizabeth M Scott, David Codyre, David Barton, Andrea Puig, Jarrad King, Gero Joks, Ian B Hickie Psychiatry Research Communications |
2024 |
|
M Hopwood, A Puig, G Joks, D Codyre Australian and New Zealand Journal of Psychiatry |
2024 |
|
WHEN, HOW AND IF TO USE PHARMACOGENETICS (PGx) IN YOUR CLINICAL PRACTICE A Singh, M Hopwood Australian and New Zealand Journal of Psychiatry |
2024 |
|
INNOVATIONS IN PSYCHIATRY: SEPARATING WHEAT FROM CHAFF-AN EXPERT PANEL DISCUSSION D Castle, M Cross, C Davey, P Fitzgerald, M Galbally, J Hope, M Hopwood, S Loi, C Loo, A Singh, S Sundram Australian and New Zealand Journal of Psychiatry |
2024 |
|
Anthony Rodgers, Dilara Bahceci, Christopher G Davey, Mary Lou Chatterton, Nick Glozier, Malcolm Hopwood, Colleen Loo Australian and New Zealand Journal of Psychiatry |
2024 |